Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting ...
Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results